2022
Commentary on CDC data showing an increased risk for pediatric diabetes with COVID‐19 infection
Gujral J, Tamborlane W, Nally L. Commentary on CDC data showing an increased risk for pediatric diabetes with COVID‐19 infection. Journal Of Diabetes 2022, 14: 630-632. PMID: 36073304, PMCID: PMC9512767, DOI: 10.1111/1753-0407.13311.Peer-Reviewed Original ResearchMeSH KeywordsCenters for Disease Control and Prevention, U.S.ChildCOVID-19Diabetes MellitusHumansSARS-CoV-2United StatesConceptsCOVID-19 infectionIncidence of diabetesBody mass indexType of diabetesMortality Weekly ReportCommercial health insurancePrevention's MorbidityMass indexPediatric diabetesViral variantsSocial determinantsDisease controlDiabetesRecent CentersHealth insuranceCDC dataSignificant increaseInfectionWeekly reportsMorbidityIncidence
2017
Understanding bolus insulin dose timing: the characteristics and experiences of people with diabetes who take bolus insulin
Tamborlane WV, Pfeiffer KM, Brod M, Nikolajsen A, Sandberg A, Peters AL, Van Name M. Understanding bolus insulin dose timing: the characteristics and experiences of people with diabetes who take bolus insulin. Current Medical Research And Opinion 2017, 33: 639-645. PMID: 28008782, DOI: 10.1080/03007995.2016.1275937.Peer-Reviewed Original ResearchConceptsBolus insulinDose timingBolus insulin therapyPrevious weekType 2 diabetesExperiences of peopleInsulin therapyTreatment optionsDiabetes educationWeb-based surveyType 1DiabetesMajority of respondentsInsulinSelf-report surveyGeneralizability of findingsT2DT1DMealWeeksHypoglycemiaRespondentsTherapyBolusPotential bias
2015
Building Momentum: Taking on the Real “Issues” of Diabetes Care!
Cefalu WT, Boulton AJ, Tamborlane WV, Moses RG, LeRoith D, Greene EL, Hu FB, Bakris G, Wylie-Rosett J, Rosenstock J, Weinger K, Blonde L, de Groot M, Riddle MC, Golden S, Rich SS, D’Alessio D, Reynolds L. Building Momentum: Taking on the Real “Issues” of Diabetes Care! Diabetes Care 2015, 39: 10-12. PMID: 27606379, PMCID: PMC4822403, DOI: 10.2337/dc15-2315.Peer-Reviewed Original ResearchDiabetes MellitusHumans
2014
Status of Diabetes Care: “It Just Doesn’t Get Any Better . . . or Does It?”
Cefalu WT, Boulton AJ, Tamborlane WV, Moses RG, LeRoith D, Greene EL, Hu FB, Bakris G, Wylie-Rosett J, Rosenstock J, Weinger K, Blonde L, de Groot M, Riddle MC, Henry RR, Golden S, Rich S, Reynolds L. Status of Diabetes Care: “It Just Doesn’t Get Any Better . . . or Does It?”. Diabetes Care 2014, 37: 1782-1785. PMID: 25093231, PMCID: PMC5131856, DOI: 10.2337/dc14-1073.Peer-Reviewed Original Research
2013
Incentivizing behaviour change to improve diabetes care
Petry NM, Cengiz E, Wagner JA, Hood KK, Carria L, Tamborlane WV. Incentivizing behaviour change to improve diabetes care. Diabetes Obesity And Metabolism 2013, 15: 1071-1076. PMID: 23574494, PMCID: PMC3737360, DOI: 10.1111/dom.12111.Peer-Reviewed Original ResearchConceptsObjective behavioral criteriaReinforcement interventionCognitive factorsWeight loss effortsBehavioral criteriaBehavioral economicsTangible reinforcersFuture researchBehavior changeGreater attendanceDecision-making processHealth care settingsBlood glucose monitoringDiabetes preventionInterventionMedication adherenceDiabetes careCare settingsMedical appointmentsHealthy lifestyleGlucose monitoringReinforcersMindControversial naturePromising areasRecommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP)
Bergenstal RM, Ahmann AJ, Bailey T, Beck RW, Bissen J, Buckingham B, Deeb L, Dolin RH, Garg SK, Goland R, Hirsch IB, Klonoff DC, Kruger DF, Matfin G, Mazze RS, Olson BA, Parkin C, Peters A, Powers MA, Rodriguez H, Southerland P, Strock ES, Tamborlane W, Wesley DM. Recommendations for Standardizing Glucose Reporting and Analysis to Optimize Clinical Decision Making in Diabetes: The Ambulatory Glucose Profile (AGP). Diabetes Technology & Therapeutics 2013, 15: 198-211. PMID: 23448694, DOI: 10.1089/dia.2013.0051.Peer-Reviewed Original Research
2012
Accuracy and Precision of the Axis-Shield Afinion Hemoglobin A1c Measurement Device
Wood JR, Kaminski BM, Kollman C, Beck RW, Hall CA, Yun JP, Cengiz E, Haller MJ, Hassan K, Klingensmith GJ, Tamborlane WV. Accuracy and Precision of the Axis-Shield Afinion Hemoglobin A1c Measurement Device. Journal Of Diabetes Science And Technology 2012, 6: 380-386. PMID: 22538150, PMCID: PMC3380782, DOI: 10.1177/193229681200600224.Peer-Reviewed Original ResearchConceptsNational Glycohemoglobin Standardization ProgramPediatric practice settingsWhole blood samplesBlood samplesHigh-performance liquid chromatographyPractice settingsDCA deviceHigher A1C levelsBoronate affinity methodMeasurement of hemoglobinA1c levelsDiabetes mellitusClinic sitesA1C resultsClinical centersAfinionCapillary bloodPatient samplesCentral laboratoryConsortium sitesA1CImmunoassay methodStandardization ProgramHPLC methodAbsolute difference
2011
New-generation diabetes management: glucose sensor-augmented insulin pump therapy
Cengiz E, Sherr JL, Weinzimer SA, Tamborlane WV. New-generation diabetes management: glucose sensor-augmented insulin pump therapy. Expert Review Of Medical Devices 2011, 8: 449-458. PMID: 21728731, PMCID: PMC3177536, DOI: 10.1586/erd.11.22.Peer-Reviewed Original ResearchMeSH KeywordsBiosensing TechniquesBlood GlucoseBlood Glucose Self-MonitoringDiabetes MellitusDiabetes Mellitus, Type 1HumansInsulin Infusion SystemsConceptsSensor-augmented insulinSensor-augmented insulin pump therapyCommon chronic disorderInsulin pump therapyContinuous subcutaneous insulin infusion systemsInsulin infusion systemField of diabetesPump therapyGlucose variabilityChronic disordersChallenging diseaseContinuous glucose monitorDelivery of insulinDiabetes managementInfusion systemTherapyInsulin deliveryTechnologic advancesInsulin
2010
Statement by the American Association of Clinical Endocrinologists Consensus Panel on Continuous Glucose Monitoring
Blevins TC, Bode BW, Garg SK, Grunberger G, Hirsch IB, Jovanovič L, Nardacci E, Orzeck EA, Roberts VL, Tamborlane WV, Rothermel C. Statement by the American Association of Clinical Endocrinologists Consensus Panel on Continuous Glucose Monitoring. Endocrine Practice 2010, 16: 730-745. PMID: 21356637, DOI: 10.4158/ep.16.5.730.Peer-Reviewed Original Research
2009
A Tale of Two Compartments: Interstitial Versus Blood Glucose Monitoring
Cengiz E, Tamborlane WV. A Tale of Two Compartments: Interstitial Versus Blood Glucose Monitoring. Diabetes Technology & Therapeutics 2009, 11: s-11-s-16. PMID: 19469670, PMCID: PMC2903977, DOI: 10.1089/dia.2009.0002.Peer-Reviewed Original Research
2002
Insulin pump therapy in the 21st century
Bode BW, Tamborlane WV, Davidson PC. Insulin pump therapy in the 21st century. Postgraduate Medicine 2002, 111: 69-77. PMID: 12040864, DOI: 10.3810/pgm.2002.05.1200.Peer-Reviewed Original ResearchPrevalence of Impaired Glucose Tolerance among Children and Adolescents with Marked Obesity
Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S. Prevalence of Impaired Glucose Tolerance among Children and Adolescents with Marked Obesity. New England Journal Of Medicine 2002, 346: 802-810. PMID: 11893791, DOI: 10.1056/nejmoa012578.Peer-Reviewed Original ResearchConceptsImpaired glucose toleranceType 2 diabetesC-peptide levelsGlucose toleranceGlucose tolerance testBeta-cell functionInsulin resistanceObese childrenInsulin levelsObese adolescentsGlucose levelsTwo-hour oral glucose tolerance testImpaired oral glucose toleranceOvert type 2 diabetesOral glucose tolerance testHomeostatic model assessmentOral glucose toleranceBody mass indexLevels of proinsulinBeta-cell failureIngestion of glucoseRatio of proinsulinSevere obesityMarked obesityChildhood obesity
1988
Insulin Resistance and Hyperinsulinemia in Patients with Thalassemia Major Treated by Hypertransfusion
Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, Tamborlane WV. Insulin Resistance and Hyperinsulinemia in Patients with Thalassemia Major Treated by Hypertransfusion. New England Journal Of Medicine 1988, 318: 809-814. PMID: 3281000, DOI: 10.1056/nejm198803313181303.Peer-Reviewed Original ResearchConceptsInsulin resistanceInsulin levelsThalassemia majorInsulin-stimulated glucose metabolismC-peptide levelsDevelopment of diabetesOral glucose administrationPlasma insulin levelsHypertransfusion therapyPubertal patientsPrepubertal patientsDiabetes mellitusGlucose toleranceInsulin deficiencyPubertal childrenGlucose administrationInsulin secretionIron overloadPrepubertal childrenChelation therapyPubertal subjectsGlucose metabolismBeta cellsHyperglycemic stimulusPatients
1979
Insulin-infusion pump for diabetes.
Felig P, Tamborlane W, Sherwin R, Genel M. Insulin-infusion pump for diabetes. New England Journal Of Medicine 1979, 301: 1004-5. PMID: 492219.Peer-Reviewed Original Research